Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Former RBS head takes the reins as GSK chair

Philip Hampton comes in at a tumultuous time for the firm

- PMLiVE

AZ and Sutter Health enter cardiometabolic collaboration

Three-year partnership will design and pilot new treatments

- PMLiVE

WHO warns on hepatitis C drug pricing

The global health body adds new therapies to its ‘essential medicines’ list

- PMLiVE

Amarin sues FDA over off-label policy

Claims block on discussing off-label uses conflicts freedom of speech

EU flag

Mid-sized European biotechs ‘need more support’

New report finds that the industry is fairing better in the US than in the EU

- PMLiVE

Sales reps in the digital age

As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?

- PMLiVE

J&J takes external advice on compassionate use

Drugmaker will run a pilot for a review of one late-stage project

- PMLiVE

Novartis biosimilar blocked by US court

Swiss firm’s Neupogen copy has its injunction upheld at appeal

- PMLiVE

EMA clears Novartis’ lung cancer drug Zykadia

First treatment option in Europe for patients with ALK-postitive NSCLC

- PMLiVE

GSK shelves ViiV sale as it lays out growth strategy

Firm now bullish on the HIV joint pharma project’s prospects

EU flag

EMA to stop ‘revolving doors’ committee members

Comes nearly five years after its former director left for a pharma service firm

- PMLiVE

Heart drug sales continue downward spiral

But revenue has stabilised after a tough three years of patent expiries

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links